Summary
Oculocutaneous albinism (OCA) is an inherited disorder of the melanin pigmentary system, characterized by a decrease or an absence of melanin in the skin, hair, and eyes. Type I (tyrosinase-deficient) OCA results from mutations of thetyrosinase (TYR) gene encoding tyrosinase, the enzyme that catalyzes at least the first two steps of melanin biosynthesis. We have analyzed theTYR gene in three Korean patients with severe type I OCA. Two patients were compound heterozygotes for the Arg (CGG) to Gln (CAG) mutation at position 77 and a C insertion mutation at position 310. The other was a compound heterozygote for a C insertion mutation at position 310 and the Asp (GAT) to Asn (AAT) mutation at position 383. These mutations were easily detected by restriction enzyme digestion or by SSCP analysis. Such methods of mutation analysis thus provide a basis for a screening system for theTYR gene mutations in Korean patients with type I OCA.
Similar content being viewed by others
Article PDF
References
Giebel LB, Strunk KM, Spritz RA (1991): Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics9: 1–11
King RA, Summers CG (1988): Albinism. Dermatol Clin6: 217–228
Korner AM, Pawelek JM (1982): Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science217: 1163–1165
Oetting WS, King RA (1994): Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1). Pigm Cell Res7: 285–290
Orita M, Iwahana H, Kanazawa H, Hayashi K, Seika T (1989): Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA86: 2766–2770
Park KC, Chintamaneni CD, Halaban R, Witkop CJ Jr, Kwon BS (1993): Molecular analysis of a tyrosinase-negative albino family. Am J Hum Genet52: 406–413
Pomeranz SH (1966): Tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem241: 161–168
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science239: 487–491
Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA74: 5463–5467
Spritz RA (1994): Molecular genetics of oculocutaneous albinism. Hum Mol Genet3: 1469–1475
Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S (1990): Molecular basis of tyrosinase-negative oculocutaneous albinism. J Biol Chem265: 17792–17797
Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S (1989): Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun164: 990–996
Witkop CJ Jr (1989): Albinism. Clin Dermatol7: 80–91
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Park, K.C., Park, S.K., Lee, Y.S. et al. Mutations of theTyrosinase gene in three Korean patients with Type I oculocutaneous albinism. Jap J Human Genet 41, 299–305 (1996). https://doi.org/10.1007/BF01913172
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01913172
Key Words
This article is cited by
-
Molecular analysis of Korean patients with oculocutaneous albinism
Japanese Journal of Ophthalmology (2012)
-
DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1)
Japanese Journal of Human Genetics (1997)